Skip to main content

Banco Macro Releases Q3 2025 Financial Statements Highlighting Lending Growth

Tipranks - Thu Dec 18, 2025

Claim 50% Off TipRanks Premium and Invest with Confidence

The latest update is out from Banco Macro SA ( (BMA) ).

Banco Macro SA has released its condensed interim financial statements for the fiscal period ending September 30, 2025, outlining its financial position, operations, and related developments. The report highlights a decrease in cash and bank deposits compared to December 31, 2024, reflecting potential adjustments in liquidity management. The bank has also showcased growth in loans and other financing as a key aspect of its operational activities, signaling a strong focus on expanding lending operations. These updates provide a comprehensive view of the bank’s performance and underline critical trends impacting its stakeholders and the Argentine banking industry.

The most recent analyst rating on (BMA) stock is a Hold with a $80.00 price target. To see the full list of analyst forecasts on Banco Macro SA stock, see the BMA Stock Forecast page.

Spark’s Take on BMA Stock

According to Spark, TipRanks’ AI Analyst, BMA is a Neutral.

Banco Macro’s overall stock score reflects a mix of strong revenue growth and a solid balance sheet, tempered by modest profitability and significant challenges highlighted in the recent earnings call. Technical indicators show positive momentum, but the financial performance and earnings call concerns weigh heavily on the score.

To see Spark’s full report on BMA stock, click here.

More about Banco Macro SA

Banco Macro SA is a commercial bank headquartered in Buenos Aires, Argentina. As an Argentine private bank authorized by the Central Bank of Argentina, it focuses on providing a variety of financial services, including loans, deposits, and other banking operations, serving individuals, businesses, and corporate clients in the Argentine market.

Average Trading Volume: 712,388

Technical Sentiment Signal: Strong Buy

Current Market Cap: $5.93B

See more data about BMA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.